Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6-8
pubmed:dateCreated
2008-11-25
pubmed:abstractText
An elevated level of Homocysteine (Hcy) is a risk factor for vascular dementia and stroke. Cysthathionine beta Synthase (CBS) gene is involved in the clearance of Hcy. Homozygous individuals for (CBS-/-) die early, but heterozygous for (CBS-/+) survive with high levels of Hcy. The gamma-Amino Butyric Acid (GABA) presents in the central nervous system (CNS) and functions as an inhibitory neurotransmitter. Hcy competes with GABA at the GABA(A) receptor and affects the CNS function. We hypothesize that Hcy causes a decrease in blood flow to the brain due to increase in vascular resistance (VR) because of arterial remodeling in the carotid artery (CA). Blood pressure and blood flow in CA of wild type (WT), CBS-/+, CBS-/+ GABA(A)-/- double knockout, and GABA(A)-/- were measured. CA was stained with trichrome, and the brain permeability was measured. Matrix Metalloproteinases (MMP-2 and MMP-9), tissue inhibitor of metalloproteinase (TIMP-3, TIMP-4), elastin, and collagen-III expression were measured by real-time polymerase chain reaction (RT-PCR). Results showed an increase in VR in CBS-/+/GABA(A)-/-double knockout>CBS-/+/>GABA(A)-/- compared to WT mice. Increased MMP-2, MMP-9, collagen-III and TIMP-3 mRNA levels were found in GABA(A)-/-, CBS-/+, CBS-/+/GABA(A) double knockout compared to WT. The levels of TIMP-4 and elastin were decreased, whereas the levels of MMP-2, MMP-9 and TIMP-3 increased, which indirectly reflected the arterial resistance. These results suggested that Hcy caused arterial remodeling in part, by increase in collagen/elastin ratio thereby increasing VR leading to the decrease in CA blood flow.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-10082471, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-10408531, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-11351038, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-11417852, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-12446535, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-12649522, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-12728267, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-12814391, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-15555590, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-16085680, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-16368548, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-1653668, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-16627783, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-16757816, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-17020760, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-17250680, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-17541043, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-17726491, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-18080868, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-18393909, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-5792556, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-6319125, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-8062427, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-9182583, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-9252358, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-9324062, http://linkedlifedata.com/resource/pubmed/commentcorrection/18725259-9509248
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0197-0186
pubmed:author
pubmed:issnType
Print
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
214-9
pubmed:dateRevised
2010-9-10
pubmed:meshHeading
pubmed-meshheading:18725259-Animals, pubmed-meshheading:18725259-Brain Ischemia, pubmed-meshheading:18725259-Carotid Arteries, pubmed-meshheading:18725259-Cerebrovascular Circulation, pubmed-meshheading:18725259-Collagen, pubmed-meshheading:18725259-Collagen Type III, pubmed-meshheading:18725259-Cystathionine beta-Synthase, pubmed-meshheading:18725259-Down-Regulation, pubmed-meshheading:18725259-Elastin, pubmed-meshheading:18725259-Homocysteine, pubmed-meshheading:18725259-Matrix Metalloproteinases, pubmed-meshheading:18725259-Mice, pubmed-meshheading:18725259-Mice, Inbred C57BL, pubmed-meshheading:18725259-RNA, Messenger, pubmed-meshheading:18725259-Receptors, GABA-A, pubmed-meshheading:18725259-Tissue Inhibitor of Metalloproteinases, pubmed-meshheading:18725259-Up-Regulation, pubmed-meshheading:18725259-Vascular Resistance, pubmed-meshheading:18725259-gamma-Aminobutyric Acid
pubmed:year
2008
pubmed:articleTitle
Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery.
pubmed:affiliation
Department of Physiology & Biophysics, University of Louisville School of Medicine, Louisville, KY 40202, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural